WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) today announced their support of the release of the “2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults,” which recommends use of statin therapy for patients across four major groups at risk for a heart attack, stroke or major cardiovascular event. This guideline was issued jointly by the American College of Cardiology (ACC) and American Heart Association (AHA).
Help employers find you! Check out all the jobs and post your resume.
